Brief: China regenerative medicine says its unit entered into sale and purchase agreement with transferor, debtor Deng and Hua

China Regenerative Medicine International

01/11/2016 12:01

Nov 1 (Reuters) - China Regenerative Medicine International 
Ltd  8158.HK - 
    * Entered into sale and purchase agreement with transferor, 
debtor Deng and Hua 
    * Deal in relation to acquisition by transferee of debt 
receivables and associated security package from transferor 
    * Deal for consideration of RMB520  million 
    * Transferee is Shaanxi Reshine Biotech and  transferor is 
Ding Feng Hospital Management 
 
Source text (http://bit.ly/2fd08bA) 
Further company coverage:  8158.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))